Immune-based therapy shows promise.
D016915:AIDS Vaccines / Q000627:therapeutic use*; D000276:Adjuvants, Immunologic; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D007558:Italy; D008297:Male; D015337:Multicenter Studies as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013030:Spain; D015996:Survival Rate; D016896:Treatment Outcome
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; C105086:remune